As shown in Figure 7B, the expression of genes tightly linked to the cytolytic activity of CD8+ T cells was significantly enhanced in PBS treated CD8+ T cells from metastatic melanoma patients with skin type 2/3 compared to healthy controls possibly pointing to ongoing anti-tumoral immune responses. This evidence concerns the gene CD8A and metastatic melanoma.